Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Docetaxel and Carboplatin in Resected NSCLC
NCT00883675Phase 4Completed
- Start
- May 2009
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of docetaxel and carboplatin in non-small cell lung cancer (NSCLC). Primary endpoint: Febrile Neutropenia Rate at 2 months. Started May 2009; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00883675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883675.